Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Luke

Showing results (21-30 of 422) with videos related to

Pageof 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Autoantibodies as Predictors for Clinical Outcome and Toxicity for ImmunotherapyJessica C Hassel, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Uncovering the Potential of CD40 Agonism to Enhance Immune Checkpoint BlockadeRichard C Wu, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
PD-1 Monotherapy Reigns Supreme in Adjuvant Melanoma…But for How Long?Ryan C Augustin, Jason J Luke
Seminars in Oncology|April 10, 2012
Advances in the systemic treatment of cutaneous sarcomasJason J Luke, Mary Louise Keohan
Nature Cell Biology|March 3, 2011
Necrotic cell death: harnessing the Dark side of the Force in mammary gland involutionCliff J Luke, Gary A Silverman
Biochimica Et Biophysica Acta|December 1, 1976
Studies on the enzymatic synthesis of enterochelin in Escherichia coli K-12. Four polypeptides involved in the conversion of 2,3-dihydroxybenzoate to enterochelinK T Greenwood, R J Luke
Microbiology (Reading, England)|March 1, 1995
Identification of a 29 kDa flagellar sheath protein in Helicobacter pylori using a murine monoclonal antibodyC J Luke, C W Penn
Future Oncology (London, England)|May 11, 2022
A plain language summary from pembrolizumab plus ipilimumab following PD-1 antibody failure in melanomaDaniel J Olson, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
CD16+ Macrophages: An Emerging Biomarker for Combined CTLA-4 and PD-1 BlockadeJames W Smithy, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2024
NETosis Impact on Tumor Biology, Radiation, and Systemic Therapy ResistanceYvonne M Mowery, Jason J Luke
Pageof 43

Showing results (21-30 of 422) with videos related to

Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Autoantibodies as Predictors for Clinical Outcome and Toxicity for ImmunotherapyJessica C Hassel, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Uncovering the Potential of CD40 Agonism to Enhance Immune Checkpoint BlockadeRichard C Wu, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
PD-1 Monotherapy Reigns Supreme in Adjuvant Melanoma…But for How Long?Ryan C Augustin, Jason J Luke
Seminars in Oncology|April 10, 2012
Advances in the systemic treatment of cutaneous sarcomasJason J Luke, Mary Louise Keohan
Nature Cell Biology|March 3, 2011
Necrotic cell death: harnessing the Dark side of the Force in mammary gland involutionCliff J Luke, Gary A Silverman
Biochimica Et Biophysica Acta|December 1, 1976
Studies on the enzymatic synthesis of enterochelin in Escherichia coli K-12. Four polypeptides involved in the conversion of 2,3-dihydroxybenzoate to enterochelinK T Greenwood, R J Luke
Microbiology (Reading, England)|March 1, 1995
Identification of a 29 kDa flagellar sheath protein in Helicobacter pylori using a murine monoclonal antibodyC J Luke, C W Penn
Future Oncology (London, England)|May 11, 2022
A plain language summary from pembrolizumab plus ipilimumab following PD-1 antibody failure in melanomaDaniel J Olson, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
CD16+ Macrophages: An Emerging Biomarker for Combined CTLA-4 and PD-1 BlockadeJames W Smithy, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2024
NETosis Impact on Tumor Biology, Radiation, and Systemic Therapy ResistanceYvonne M Mowery, Jason J Luke
Pageof 43